Latest news
25 items- PRRockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of DirectorsBrings more than 20 years of experience as an entrepreneur scientist, CEO, operator, investor, and board member of public and private biopharmaceutical companies Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company appointed Joan Lau, Ph.D. to its board of directors. Dr. Lau's appointment increases Rockwell Medical's board of directors to seven members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231017906241/en/RMTI) (Photo: Business Wire)"
- 13D/GSEC Form SC 13D/A filed by Renovacor Inc. (Amendment)SC 13D/A - Renovacor, Inc. (0001799850) (Subject)
- INSIDERSEC Form 4 filed by Rtw Investments, Lp4 - Renovacor, Inc. (0001799850) (Issuer)
- 13D/GSEC Form SC 13G/A filed by Renovacor Inc. (Amendment)SC 13G/A - Renovacor, Inc. (0001799850) (Subject)
- SECSEC Form 15-12G filed by Renovacor Inc.15-12G - Renovacor, Inc. (0001799850) (Filer)
- SECSEC Form EFFECT filed by Renovacor Inc.EFFECT - Renovacor, Inc. (0001799850) (Filer)
- SECSEC Form EFFECT filed by Renovacor Inc.EFFECT - Renovacor, Inc. (0001799850) (Filer)
- INSIDERSEC Form 4 filed by Needham Thomas E. Jr.4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4 filed by Lau Joan4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Grossman Jonas returned 394,657 shares to the company, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4 filed by Covino Gregory F4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Benz Edward J. Jr was granted 3,586 shares and returned 3,586 shares to the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Amusa Gbolahan returned 278,588 shares to the company, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Killeen Matthew returned 5,275 shares to the company, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Semigran Marc returned 52,651 shares to the company and was granted 35,226 shares, closing all direct ownership in the company (withholding obligation)4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Carroll Joseph S returned 8,195 shares to the company, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Dicicco Wendy F returned 23,129 shares to the company and was granted 4,329 shares, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- INSIDERSEC Form 4: Cook Magdalene was granted 147,083 shares and returned 669,356 shares to the company, closing all direct ownership in the company4 - Renovacor, Inc. (0001799850) (Issuer)
- SECSEC Form S-8 POS filed by Renovacor Inc.S-8 POS - Renovacor, Inc. (0001799850) (Filer)
- SECSEC Form S-8 POS filed by Renovacor Inc.S-8 POS - Renovacor, Inc. (0001799850) (Filer)
- SECSEC Form POS AM filed by Renovacor Inc.POS AM - Renovacor, Inc. (0001799850) (Filer)
- SECSEC Form POS AM filed by Renovacor Inc.POS AM - Renovacor, Inc. (0001799850) (Filer)
- SECRenovacor Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Renovacor, Inc. (0001799850) (Filer)
- PRRocket Pharmaceuticals Completes Acquisition of RenovacorAcquisition further extends Rocket's leadership in AAV-based cardiac gene therapy and expands focus and capabilities to BAG3-associated dilated cardiomyopathy Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need, today announces that it has completed the previously announced acquisition of Renovacor, Inc. (NYSE:RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Under the terms of t
- SECSEC Form 25-NSE filed by Renovacor Inc.25-NSE - Renovacor, Inc. (0001799850) (Subject)
RCOR FAQ
6 questionsWhere does RCOR stock trade?
Renovacor Inc. (RCOR) is listed on AMEX.What sector and industry is RCOR in?
Renovacor Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Renovacor Inc. go public?
Renovacor Inc. (RCOR) completed its IPO in 2020.What are analysts saying about RCOR?
Renovacor Inc. has had 3 recent analyst actions on file. The most recent action was from Robert W. Baird: Outperform with a $900.00 price target on 2022-09-13. Recent price targets range from $900.00 to $2200.00.What companies are similar to RCOR?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare RCOR side-by-side with any of them on Quantisnow.How can I track RCOR on Quantisnow?
Quantisnow aggregates Renovacor Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RCOR to receive live email and push alerts on every new disclosure.